Advisors Asset Management’s Cellectis CLLS Stock Holding History

Advisors Asset Management’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,393	Closed	-$193K	–	1569
2019 Q2	$193K	Sell	12,393 -9,539	-43%	-$170K	﹤0.01%	1194
2019 Q1	$402K	Sell	21,932 -242	-1%	-$4.29K	0.01%	1138
2018 Q4	$369K	Sell	22,174 -714	-3%	-$16.6K	0.01%	1055
2018 Q3	$646K	Sell	22,888 -1,171	-5%	-$33.6K	0.01%	973
2018 Q2	$681K	Sell	24,059 -1,463	-6%	-$43.6K	0.01%	956
2018 Q1	$797K	Sell	25,522 -1,323	-5%	-$41.8K	0.01%	924
2017 Q4	$783K	Buy	26,845 +4,253	+19%	+$116K	0.01%	945
2017 Q3	$643K	Buy	22,592 +21,181	+1,501%	+$548K	0.01%	1000
2017 Q2	$36K	Buy	+1,411	New	+$33.7K	﹤0.01%	1458

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Advisors Asset Management's CLLS Position: Q3 2019 in Review

Advisors Asset Management sold out of Cellectis (CLLS) in Q3 2019, closing a stake of 12,393 shares — an estimated $193K sold.

Advisors Asset Management first reported a position in CLLS in Q2 2017 and held it in 9 quarters. The position peaked at $797K in Q1 2018. 64 funds tracked by Wall St. Rank hold CLLS as of Q3 2019.

Advisors Asset Management reported no remaining Cellectis position as of Q3 2019 after selling out during the quarter.
Advisors Asset Management sold 12,393 Cellectis shares in Q3 2019, an estimated $193K.
Advisors Asset Management first reported a position in Cellectis in Q2 2017 and held it in 9 quarters.
Advisors Asset Management's Cellectis position peaked at $797K in Q1 2018.
64 funds tracked by Wall St. Rank held Cellectis as of Q3 2019.

Based on Advisors Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.